Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers believe their greater understanding of leukemia stem cells will lead to more treatment options for people with the blood cancer.
Researchers called the results of treatment using Venclexta (venetoclax) and Vidaza (azacitidine) “remarkably impressive.”
ASH 2018 conference highlights precision medicine, machine learning and gut microbiome.
The life-threatening side effect, called differentiation syndrome, is related to the acute myeloid leukemia medicine Idhifa (enasidenib).
A clinical trial showed that 21 percent of participants achieved complete remission.
Daurismo (glasdegib) plus chemotherapy improved overall survival in clinical trial.
NK cells are “first responders” that rapidly detect and attack virus-infected cells and tumor cells, and can also help prevent metastasis.
The study used two FDA-approved drugs to the pre-leukemic cells while leaving healthy stem cells alone.
Trials for head and neck cancer, pancreatic cancer, acute myeloid leukemia and myelodysplastic syndrome, among others, will receive funding.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.